Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know

Company Performance - Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.85, reflecting a +2.39% change from the previous day, outperforming the S&P 500's daily loss of 0.53% [1] - Over the past month, the company's shares have gained 16.47%, significantly exceeding the Medical sector's gain of 0.09% and the S&P 500's gain of 2.06% [1] Earnings Projections - The upcoming earnings disclosure is projected to show earnings per share (EPS) of -$1.8, which is a 1.1% increase from the same quarter last year [2] - Revenue is anticipated to be $37 million, indicating a 15.62% decrease from the same quarter last year [2] Full-Year Estimates - The full-year Zacks Consensus Estimates predict earnings of -$5.94 per share and revenue of $173 million, representing year-over-year changes of +42.66% for earnings and 0% for revenue [3] - Recent changes to analyst estimates for Ginkgo Bioworks should be monitored as they reflect evolving short-term business trends [3] Zacks Rank and Industry Performance - Ginkgo Bioworks currently holds a Zacks Rank of 3 (Hold), with no changes in the Zacks Consensus EPS estimate over the past month [5] - The Medical - Biomedical and Genetics industry, part of the Medical sector, has a Zacks Industry Rank of 96, placing it in the top 40% of over 250 industries [6]